Speaker

Friso Smit | COO and Program Director, Oncode Accelerator

Friso Smit studied pharmaceutical sciences and received his PhD in the field of natural products for drug development. In 2000 he joined (Danone) Nutricia Research to work on specialized nutrition with clinically substantiated health benefits and became R&D director for collaborative innovation in 2011. He joined Utrecht Science Park foundation in 2013 as ecosystem manager and in 2022 University Medical Center Utrecht as senior business developer. From 2022 - 2023 he was also chairman of the board of the Utrecht Center for Affordable Biotherapeutics. He is co-initiator of several National Growth Fund applications and since 2023 program director and COO of the Oncode Accelerator foundation.

Oncode Accelerator

Oncode Accelerator is a public-private partnership funded by the Dutch National Growth Fund (NGF), which aims to innovate and accelerate the preclinical development of new cancer therapies represented by our four workstreams: small molecules, biologics, cell and gene therapy and therapeutic vaccines. 

Together, we believe preclinical drug discovery and therapy development can be accelerated and de-risked using an innovative combination of well-defined patient cohorts, organoid models, and artificial intelligence platforms.

Oncode Accelerator is a collaboration between six coordinating partners: Leiden University, Leiden University Medical Center, the Netherlands Cancer Institute, Princess Máxima Center, UMC Utrecht and the Oncode Accelerator Foundation.

For more information about Oncode Accelerator you can visit their website.

Powered by:
Hyphen Projects

Let's connect:

Book a ticket

FAQ
Contact Us
Privacy Policy
Terms & Conditions
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01

Keep me informed Download the sponsor brochure

© Copyright 2025 by Hyphen Projects